Decoding the risk of thromboembolic events in lymphoma patients

Multiple myeloma highlights from EHA 2016

SL401 in patients with rare neoplasm

RNA regulation of JAK-STAT pathways in CML

The value and strategy for incorporating biosimilars Into clinical practice

Neuroblastoma outcomes improved with second stem cell transplant

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer

Sequencing analysis with circulating DNA

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer.

Daratumumab slows progression in refractory multiple myeloma

First results of a prospective bendamustine/rituximab trial in patients with MCL

Performance characteristics and stage distribution of invasive epithelial ovarian/tubal/peritoneal cancers